openPR Logo
Press release

Personalized Vaccine Transforming Oncology Cancer Market With USD 5 Billion Market Size Sales Opportunity

02-28-2020 08:32 AM CET | Health & Medicine

Press release from: Kuick Resarch

The approach of treating disease by the means of personalized vaccine has totally revolutionized and shifted the treatment regimen to a brand new chapter. The radical shifting of the treatment facilities and the modification of the expression of genes of specific individual made our team to conduct survey on the current market trends followed by the concept. The research report "xxx" represents market information regarding the subject and the detailed information about the current market trends that are currently followed. The research report discusses the competitive level of the market at regional level and the useful parameters that the market is following to remain as a trending pharmaceutical field.

"Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026" Report Highlights:

o Personalized Cancer Vaccine Mechanism of Action
o Biomarkers Importance In Personalized Vaccines
o Ongoing Clinical Trials on Personalized Cancer Vaccine
o Developmental Cost Analysis of a Personalized Cancer Vaccine
o Immune Checkpoint Biomarkers Preventing Tumor Growth
o Advancements in the Personalized Cancer Vaccine
o Current Market Trends & Advancements in the Personalized Cancer Vaccine Segment

Download Report:,-clinical-trials-and-future-outlook-2026.php

Personalized vaccine allows the researchers to evaluate the condition of the individual personally and suggest a therapy that will be most provoking and prominent for the treatment. Since the arrival of developing personalized vaccine in the pharmaceutical sector, the market is expected to grow at a pace that is more than any other emerging markets of the pharmaceutical. Ongoing strong clinical pipelines and the numerous clinical trials that are underway the process reflects a brighter side of the market. The process provides the most important advantage of reducing the failure rate during any treatment process. The techniques provided by the research world such as cell culture system and many more remains as a classic support for conducting successful experiments of personalized vaccine.

The procedure bypasses the procedure of conducting experiments directly on the patients and helps in predicting a response that provides the best response prior to the actual treatment. The availability of the procedures that follow the process of personalized vaccine is continuously proving to be a major factor high market demand of the process. It is observed by conducting the survey on the recent trends of personalized vaccine that the sector of healthcare has experienced a major turning point and will follow the same in the coming years. Growing incidence of deadly diseases and the increasing economic strengths of the families are some of the key factors that are highly responsible for the lucrative growth of the market.

Table of Contents

1. Personalized Cancer Vaccine: Revolutionizing the Immunotherapeutics of the Future

1.1 The Approach Towards Cancer Vaccine Strategy
1.2 Cancer Vaccines - Current Clinical Trials Scenario

2. Personalized Cancer Vaccine Mechanism of Action

2.1 Entities Involved in Personalized Cancer Vaccine & Their Respective Contributions
2.1.1 Tumor Neo - Antigens
2.1.2 Human Leukocyte Antigen
2.2 General Working of Personalized Cancer Vaccine
2.3 Genetic Polymorphism Leading to Pharmacogenomics
2.4 Cancer Pharmacogenomics Observing Somatic Mutations

3. Biomarkers Importance In Personalized Vaccines

3.1 Pharmacogenomic Biomarkers
3.2 Prognostic & Predictive Biomarkers

4. Ongoing Clinical Trials on Personalized Medicines

4.1 NEO-PV-01 Showing Glimmers of Success against Melanoma
4.2 Personalized Vaccine: An Evolving Biological Discovery for Pancreatic Cancer
4.3 Precision Cancer Vaccine against Metastatic Colorectal Cancer
4.4 First-in-Human Trial of Personalized Vaccine for Glioblastoma (Brain Tumor)
4.5 TG4001 in Combination with Avelumab against HPV Cancers

5. Immune Checkpoint Biomarkers Preventing Tumor Growth

5.1 Emerging Biomarkers for CTLA4
5.2 PD-1/PD-L1

6. Personalized Cancer Vaccine: Manufacturing Process & Cost Analysis Study

6.1 Pre - Manufacturing Cost Analysis
6.2 Segmented Cost Analysis of Personalized Cancer Vaccine
6.2.1 Capital Cost
6.2.2 Cost of Raw Materials
6.2.3 Annual Cost of Personnel Involved in Cancer Vaccine Manufacture
6.2.4 Factory & Administrative Overheads
6.2.5 Filling & Packaging
6.3 Per Patient Cost

7. Current Market Trends & Advancements in the Personalized Cancer Vaccine Segment

7.1 Researchers Improving the Outcome of Future Personalized Cancer Vaccine
7.2 Increasing Investments
7.3 Personalized Cancer Vaccine Development using mRNA
7.4 Personalized Cancer Vaccine Market Receiving Collaborations & Ventures Ensure Stable Funding
7.5 DNA Sequencing Technology Development Driving the Personalized Cancer Vaccine Market

8. Global - Personalized Cancer Vaccine Market Segmentation by Cancer Type

8.1 Personalized Cancer Vaccine Breakthrough against Melanoma
8.2 Lung Cancer Prevention using Personalized Vaccines
8.3 Personalized Cancer Vaccines towards Eliminating Breast Cancer
8.4 Colorectal Cancer Eradication by Personalized Cancer Vaccines
8.5 Scope of Leukemia Treatment using Personalized Cancer Vaccines
8.6 Prostate Cancer Eradication using Personalized Cancer vaccine: Provenge
8.7 Personalized Cancer Vaccines Targeting Cervical Cancer
8.8 Personalized Cancer Vaccines Application towards Glioblastoma (Brain Tumor)

9. Personalized Cancer Vaccine: Rising with New Avenues & Opportunities

9.1 Insights into the Personalized Cancer Vaccine Clinical Pipeline
9.2 Opportunities for Personalized Cancer Vaccine in the Emerging Market of the World

10. Porter's Five Force Analysis of the Personalized Cancer Vaccine Market

10.1 Bargaining Power of Suppliers
10.2 Bargaining Power of Buyer
10.3 Threats of Substitute Products
10.4 Threat of New Entrants to the already Existing Market
10.5 Rivalry Among the Existing Competitors

11. Factors Driving the Market of Personalized Cancer Vaccine

11.1 Increased Demand for Personalized Cancer Vaccine Production
11.2 Increase Prevalence of Cancer Cases in the Population Worldwide
11.3 Cancer Heterogenetic Environment
11.4 High Level of Specificity
11.5 Assistance from Government
11.6 Advancements in Genome Sequencing Techniques Delivering better Personalized Cancer Vaccines
11.7 Robust Clinical Pipeline Under Development

12. Challenges Associated with Personalized Cancer Vaccine Market

12.1 Scientific & Technical Challenges in Developing a Personalized Cancer Vaccine
12.2 Commercial Challenges Surrounding Personalized Cancer Vaccines

13. Global Personalized Cancer Vaccine Market Future Outlook

14. Personalized Medicine Current Market Region Scenario

14.1 North America
14.2 Latin America
14.3 Europe
14.4 Asia-Pacific
14.4.1 Japan
14.4.2 India
14.4.3 South Korea
14.4.4 Taiwan
14.5 Middle East & Africa

15. Global Personalized Vaccine Trends

16. Competitive Landscape

16.1 Advaxis Inc.
16.2 Avax Technologies
16.3 BioNtech AG
16.4 Celldex
16.5 CureVac AG
16.6 Genetech
16.7 Genocea
16.8 Gristone Oncology
16.9 ISA Pharmaceuticals
16.10 Merck
16.11 Moderna Therapeutics
16.12 Neon Therapeutics
16.13 Personalis

Kuick Research
Delhi,India,Tel; +91-11-47067990

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Vaccine Transforming Oncology Cancer Market With USD 5 Billion Market Size Sales Opportunity here

News-ID: 1949128 • Views: 202

More Releases from Kuick Resarch

Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy
Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …
Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027 "Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market: > USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Cell Therapy Price & Product Insight By Region/Country • Clinical
Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …
"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026 • USA Dominates Global Small Molecule Cancer Drug Market: >50% Share • Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs • Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs • Small Molecule Drug Insight by Cancer • Clinical Trials Insight
GCC Clinical Trial Market Outlook Insight 2025
"GCC Clinical Trial Market Outlook 2025" Report Highlights: • GCC Clinical Trial Market Opportunity: >US$ 500 Million • GCC Disease Prevalence & Statistics • Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials • Clinical Trials for Cancer in GCC: > 120 Trials • Guidelines For Conducting Clinical Trials by Country • Ongoing Clinical Trials Insight by Country Download Report: Table of Contents 1. GCC Clinical Market Regional Insights 2. GCC Clinical Trial Market Dynamics 2.1 Driving Forces for GCC Clinical Trial

All 5 Releases

More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,